Learn Without a Brain Research Wins 2023 UCSF Grad Slam
Ten graduate school finalists competed in this year’s UCSF Grad Slam, in which students present their research in three minutes or less in terms easily understood by a general audience.
University of California San Francisco
Give to UCSFTen graduate school finalists competed in this year’s UCSF Grad Slam, in which students present their research in three minutes or less in terms easily understood by a general audience.
After more than a decade, Jaime Sepúlveda will step down from his role as executive director of UCSF’s Institute for Global Health Sciences in August 2023.
UCSF Pediatric Dentistry’s Autism Program approaches dental care for kids with autism by creating personalized plans that will expose them to each step of a visit to increase their tolerance.
Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Diane Havlir, MD, UCSF’s Weiss Professor, an AIDS pioneer, and an infectious disease leader, is partnering with the local Latinx community to protect vulnerable San Franciscans from COVID-19 and other diseases.
Diana Greene Foster of UCSF was named one of the top 10 most influential scientists of 2022 by "Nature" for her study of what happens to women who are denied abortions.
California prisons saw more than 20,000 COVID-19 Omicron cases over a five-month period. However, vaccination and boosting kept hospitalization and death rates low.
The California Collaborative for Pandemic Recovery and Readiness Research (CPR3) at UCSF will investigate the effects of the pandemic on California communities and individuals.
Since March 2020, UCSF has partnered with government and community groups to address racial, economic and cultural barriers to provide equitable care to vulnerable people during the COVID-19 pandemic.
A third of American women of reproductive age now face excessive travel times to obtain an abortion, according to a new geospatial analysis by researchers in San Francisco and Boston that is one of the first to model the effects of the Supreme Court’s recent Dobbs v. Jackson decision.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
To support the wellbeing of the UCSF community, the University is now offering grants for projects that promote various forms of wellness.
The study, funded by the National Institute on Aging, recruited people who were 50 and older and homeless, and followed them for a median of 4.5 years. By interviewing people every six months about their health and housing status, researchers were able to examine how things like regaining housing, using drugs, and having various chronic conditions, such as diabetes, affected their risk of dying.
UCSF, San Francisco Department of Public Health (SFDPH) and San Mateo County Health (SMC Health) are partnering with local community groups to learn about long COVID. Their project, Let’s Figure Out Long COVID – Tell Us Your Story, Bay Area, will call local residents of all ethnicities and backgrounds who previously had COVID.
Overcrowding, antiquated buildings, rapidly changing conditions and the need for complex coordination helped drive a dramatic COVID-19 surge in California’s prisons, according to a new report from UCSF and UC Berkeley.
A groundbreaking UCSF study reveals the long-term adverse effects of unwanted pregnancy on people’s lives, pointing to widespread challenges that will result from the US Supreme Court ruling to overturn the constitutional right to an abortion.
The Opioid Industry Documents Archive (OIDA), a project of UCSF, and Johns Hopkins University, today released more than 114,000 documents related to McKinsey & Company's work as a management consulting firm for the opioid industry.